EUVIMEDEUVIMED entdecken
Crossref

First person – Bunu Lama and Sanjana Sundararajan

Journal of Cell Science · 15.10.2026 · 139 (20)

DOI: 10.1242/jcs.265383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Science, online erschienen am 29.10.2026. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping researchers promote themselves alongside their papers. Bunu Lama and Sanjana Sundararajan are co-first authors on ‘ Contribution of topoisomerase IIα chromatin-tether and C-terminal domain to mitotic chromosome association and structural organization’, published in JCS. Bunu conducted the research described in this article while a PhD Student in Dr Yoshiaki Azuma's lab at University of Kansas. She is now a post-doc in the lab of Dr Duncan Clarke at the University of Minnesota, investigating the molecular mechanisms that maintain genome integrity and ensure accurate chromosome segregation, with a particular interest in targeting these processes for cancer therapy. Sanjana undertook this work in Dr Yoshiaki Azuma's lab as a graduate student and is now a postdoc in Dr Mary Dasso's lab at the National Institutes of Health. Her current research investigates mechanisms involving the interplay between nuclear pore complexes and chromosome segregation, as well as the impact of these processes on genomic integrity, human health and development.

Zitieren

APA

(2026). First person – Bunu Lama and Sanjana Sundararajan. Journal of Cell Science, 139(20). https://doi.org/10.1242/jcs.265383

Vancouver

First person – Bunu Lama and Sanjana Sundararajan. Journal of Cell Science. 2026;139(20). doi:10.1242/jcs.265383

BibTeX
@article{euvimed2026,
  title = {First person – Bunu Lama and Sanjana Sundararajan},
  journal = {Journal of Cell Science},
  year = {2026},
  volume = {139},
  number = {20},
  doi = {10.1242/jcs.265383}
}
Kostenlos starten →